Holen Sie sich die Stockscreener-App
70.46
2.21%
1.525
Handel nachbörslich:
70.65
0.19
+0.27%
Schlusskurs vom Vortag:
$68.94
Offen:
$68.28
24-Stunden-Volumen:
1.55M
Relative Volume:
1.23
Marktkapitalisierung:
$2.44B
Einnahmen:
$605.49M
Nettoeinkommen (Verlust:
$190.29M
KGV:
14.51
EPS:
4.8571
Netto-Cashflow:
$133.59M
1W Leistung:
+6.55%
1M Leistung:
-36.48%
6M Leistung:
-51.66%
1J Leistung:
-43.29%
1-Tages-Spanne:
$68.25
$71.14
1-Wochen-Bereich:
$64.66
$71.14
52-Wochen-Spanne:
$60.10
$156.00
Transmedics Group Inc Stock (TMDX) Company Profile
Firmenname
Transmedics Group Inc
Sektor
Branche
Telefon
(978) 552-0900
Adresse
200 MINUTEMAN ROAD, ANDOVER, MA
Compare TMDX vs ABT, SYK, MDT, BSX, EW
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TMDX
Transmedics Group Inc
|
70.46 | 2.38B | 605.49M | 190.29M | 133.59M | 4.8571 |
ABT
Abbott Laboratories
|
86.67 | 152.25B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
313.00 | 121.33B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
77.60 | 100.91B | 35.48B | 4.64B | 5.41B | 3.582 |
BSX
Boston Scientific Corp
|
57.64 | 85.88B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
87.54 | 49.39B | 6.30B | 1.07B | 1.09B | 1.8406 |
Transmedics Group Inc Stock (TMDX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-10-23 | Hochstufung | Needham | Hold → Buy |
| 2025-10-13 | Eingeleitet | Jefferies | Buy |
| 2025-09-16 | Eingeleitet | Evercore ISI | Outperform |
| 2025-09-04 | Eingeleitet | Stifel | Hold |
| 2024-12-17 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2024-11-22 | Herabstufung | Needham | Buy → Hold |
| 2024-10-29 | Bestätigt | Needham | Buy |
| 2024-10-29 | Bestätigt | Oppenheimer | Outperform |
| 2024-09-24 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-08-21 | Eingeleitet | Needham | Buy |
| 2024-06-06 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2024-06-04 | Eingeleitet | Stephens | Overweight |
| 2024-03-28 | Eingeleitet | Piper Sandler | Overweight |
| 2023-07-19 | Eingeleitet | Robert W. Baird | Outperform |
| 2022-08-02 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2020-10-08 | Herabstufung | JP Morgan | Overweight → Neutral |
| 2020-04-07 | Eingeleitet | Oppenheimer | Outperform |
| 2019-05-28 | Eingeleitet | Canaccord Genuity | Buy |
| 2019-05-28 | Eingeleitet | Cowen | Outperform |
| 2019-05-28 | Eingeleitet | JP Morgan | Overweight |
| 2019-05-28 | Eingeleitet | Morgan Stanley | Equal-Weight |
Alle ansehen
Transmedics Group Inc Aktie (TMDX) Neueste Nachrichten
TMDX Maintained by Stifel -- Price Target Lowered to $75.00 - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Trades & News - GuruFocus
Stifel Nicolaus Lowers TransMedics Group (NASDAQ:TMDX) Price Target to $75.00 - MarketBeat
Stifel cuts TransMedics stock price target on heart market weakness - Investing.com
TransMedics: Despite Earnings Miss, Growth Story Remains Intact (NASDAQ:TMDX) - Seeking Alpha
TransMedics Group, Inc. (TMDX) Stock Analysis: Unveiling a 71% Potential Upside in the Medical Device Sector - DirectorsTalk Interviews
TransMedics Group Inc Stock Warning Signs | MIL:1TMDX - GuruFocus
TransMedics Group Inc (TMDX) Stock Price, Quote, News & History - Benzinga
TransMedics (TMDX) director receives 2,922 RSU award, holds 5,788 shares - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSUs, lifting holdings to 15,056 shares - Stock Titan
TransMedics (TMDX) director Merilee Raines receives 2,922 RSU award - Stock Titan
TransMedics (TMDX) director receives 2,922 RSUs in equity grant - Stock Titan
Director at TransMedics (TMDX) receives 2,922 RSU equity grant, holds 5,788 shares - Stock Titan
[Form 4] TransMedics Group, Inc. Insider Trading Activity - Stock Titan
TransMedics (TMDX) director Edwin Kania awarded 2,922 RSUs, now holds over 300K shares - Stock Titan
TMDX Stock Price, Quote & Chart | TRANSMEDICS GROUP INC (NASDAQ:TMDX) - ChartMill
TransMedics (TMDX) officer receives RSU and stock option grants tied to service - Stock Titan
TransMedics (NASDAQ: TMDX) investors approve directors, pay, stock plan and auditor - Stock Titan
TransMedics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) - marketscreener.com
Organ-transplant firm TransMedics hands new hires stock and RSUs - Stock Titan
TransMedics Group stock (US89366D3075): organ transplant tech in focus after conference appearance - AD HOC NEWS
Transmedics Group Inc Annual Shareholders Meeting Transcript - GuruFocus
TransMedics Group Inc (TMDX) Shares Fall 3.2% -- What GF Score o - GuruFocus
TransMedics to Present at the William Blair 46th Annual Growth Stock Conference - 富途牛牛
TransMedics Group Inc (TMDX) Shares Fall 3.2% -- What GF Score of 75 Tells Investors - GuruFocus
TransMedics Group, Inc.Common Stock (NQ: TMDX - FinancialContent
TransMedics Group Inc (NASDAQ:TMDX) Gains Momentum In Healthcare Space - Kalkine Media
TransMedics Group (NASDAQ:TMDX) Shares Up 7.1%Here's What Happened - MarketBeat
TransMedics Group, Inc. (TMDX) Stock Analysis: A Compelling 86% Upside Potential for Innovative Healthcare Investors - DirectorsTalk Interviews
Reasons to retain TransMedics stock in your portfolio for now - MSN
TransMedics Group (TMDX) price target decreased by 22.22% to 126.07 - MSN
TransMedics tumbles after earnings miss - MSN
Discipline and Rules-Based Execution in TMDX Response - Stock Traders Daily
Bryce Point Capital, LLC's TransMedics Group Inc(TMDX) Holding History - GuruFocus
Is TransMedics Group Inc (TMDX) a Bargain After 3.3% Drop? GF Va - GuruFocus
CFG Wealth Management Services, Inc.'s TransMedics Group Inc(TMDX) Holding History - GuruFocus
TransMedics Group (TMDX) Drops 5.1% to $60.69 - AlphaStreet
TransMedics’ vitals seem less stable, and that changes things - Finimize
TransMedics Group Inc (NASDAQ:TMDX) – A Prime Example of Affordable Growth in Medical Technology - ChartMill
TransMedics Group (NASDAQ:TMDX) Reaches New 52-Week LowHere's Why - MarketBeat
TransMedics Q1 2026 slides: revenue grows 21% amid profit squeeze By Investing.com - Investing.com Nigeria
TransMedics Q1 2026 slides: revenue grows 21% amid profit squeeze - Investing.com
Earnings call transcript: TransMedics Q1 2026 earnings miss sends stock tumbling By Investing.com - Investing.com South Africa
Earnings call transcript: TransMedics Q1 2026 earnings miss sends stock tumbling - Investing.com
TMDX dips after posting Q1 earnings & revenue miss, margins fall - MSN
Assessing TransMedics Group (TMDX) Valuation After A Sharp One Year Share Price Decline - Yahoo Finance
Wall Street Zen Downgrades TransMedics Group (NASDAQ:TMDX) to Sell - MarketBeat
Finanzdaten der Transmedics Group Inc-Aktie (TMDX)
Umsatz
Nettogewinn
Free Cashflow
ENV
Transmedics Group Inc-Aktie (TMDX) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Weill David | Director |
Mar 04 '26 |
Option Exercise |
14.20 |
3,571 |
50,708 |
15,705 |
| Weill David | Director |
Mar 04 '26 |
Sale |
146.82 |
3,571 |
524,294 |
12,134 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Option Exercise |
71.17 |
7,236 |
515,001 |
20,601 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 04 '26 |
Sale |
147.21 |
7,236 |
1,065,212 |
14,689 |
| Hernandez Gerardo | Chief Financial Officer |
Mar 02 '26 |
Sale |
139.12 |
375 |
52,170 |
14,689 |
| Ranganath Anil P. | See remarks |
Mar 02 '26 |
Sale |
139.12 |
864 |
120,200 |
13,091 |
| Corcoran Nicholas | See remarks |
Mar 02 '26 |
Sale |
139.12 |
2,966 |
412,630 |
29,831 |
1.27%
2.05%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):